Killer cell immunoglobulin-like receptor 3DL2

BE0010849ProteinHumansKIR3DL2

Receptor on natural killer (NK) cells and T cells for MHC class I molecules (PubMed:24018270, PubMed:28636952). It is acted on by 1 drug in DrugBank.

Gene name
KIR3DL2
UniProtKB entry
P43630Swiss-Prot
Cellular location
Cell membrane
Residues / weight
455 residues · 50,230 Da
Also known as
CD158 antigen-like family member K · CD158K · Natural killer-associated transcript 4 · NKAT-4 · NKAT4

Resolves to

Protein
UniProtP43630UniProt nameKI3L2_HUMAN
Gene
HGNCHGNC:6339NCBI Gene3812GeneCardsKIR3DL2
Pharmacology
KEGGhsa:3812
Drugs

What you can answer from here — as of October 31, 2023

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
1Clinical trialTrials of drugs acting on it, by phase and status
Sign in
3GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Killer cell immunoglobulin-like receptor 3DL2, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In